In the blood of MS patients, increased concentrations of neutrophil-activating chemokines and neutrophil-derived enzymes are detected (e.g., CXCL1, CXCL8, NE, MPO) and these molecules are associated with the formation of new inflammatory lesions [72,75,76]. This evidence concerns the gene MPO and myeloid sarcoma.